肌肉改变与肝硬化患者轻微型和显性肝性脑病相关
研究纳入64例肝硬化患者,用心理测量肝性脑病评分和动物命名测试检测轻微型肝性脑病(MHE),用CT分析骨骼肌指数和衰减。结果发现肌肉减少症和肌肉脂肪变性均与MHE及显性肝性脑病(HE)风险独立相关,且营养不良患者生存率显著更低。
要点
- 肌肉脂肪变性见于37.5%患者,肌肉减少症见于58%,MHE见于50%。
- 肌肉减少症和肌肉脂肪变性均与MHE及显性HE风险独立相关。
- 营养不良患者生存率显著低于无肌肉脂肪变性或肌肉减少症者(P < 0.001)。
核心结论
- 肌肉脂肪变性和肌肉减少症可能通过减少肌肉对氨的处理,与肝硬化患者MHE及显性HE风险独立相关;在营养不良患者中,改善营养状态可能是降低MHE患病率和显性HE发生率的目标。
研究设计与样本
- 研究纳入64例肝硬化患者,使用心理测量肝性脑病评分和动物命名测试检测MHE,用计算机断层扫描分析骨骼肌指数和衰减,并考虑竞争风险估计首次HE发作的 incidence。
主要发现
- 肌肉脂肪变性见于24例(37.5%),肌肉减少症见于37例(58%),MHE见于32例(50%)。
- MHE患者中肌肉脂肪变性比例更高(62.5% vs 12.5%,P < 0.001),肌肉减少症比例也更高(84% vs 31%,P < 0.001)。
- 与MHE presence独立相关的变量为肌肉减少症、既往显性HE和肌肉脂肪变性。
- 31例(48%)患者在16.1 ± 13个月内发生显性HE,其中68%存在肌肉脂肪变性,84%存在肌肉减少症。
- 肌肉减少症患者静脉血氨显著更高(62.6 ± 17.7 vs 41.4 ± 16.1 μg/dL,P < 0.001),肌肉脂肪变性患者也更高(65.2 ± 19.2 vs 46.7 ± 17.1 μg/dL,P < 0.001),且血氨与两者均呈负相关。
临床怎么用
- 作者认为,在营养不良患者中改善营养状态可能是降低MHE患病率和显性HE发生率的目标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Muscle alterations (myosteatosis and sarcopenia) are frequent in cirrhosis and related to some complications including overt hepatic encephalopathy (HE). The aim of our study was to investigate the relationship between muscle alterations and minimal HE (MHE) and their role in the risk of overt HE. Sixty-four patients with cirrhosis were administered the Psychometric Hepatic Encephalopathy Score and animal naming test to detect MHE. Computed tomography was used to analyze the skeletal muscle index and attenuation. The incidence of the first episode of HE, taking into account the competing risk nature of the data, was estimated. Myosteatosis was observed in 24 patients (37.5%), sarcopenia in 37 (58%), and MHE in 32 (50%). Both myosteatosis (62.5% versus 12.5%, P < 0.001) and sarcopenia (84% versus 31%, P < 0.001) were more frequent in patients with MHE. The variables independently associated with the presence of MHE were sarcopenia, previous overt HE, and myosteatosis. Thirty-one (48%) patients developed overt HE over 16.1 ± 13 months; myosteatosis was detected in 68% and sarcopenia in 84% of them. Sarcopenia and myosteatosis were also independently associated with the development of overt HE. Venous ammonia was significantly higher in patients with sarcopenia (62.6 ± 17.7 versus 41.4 ± 16.1 μg/dL, P < 0.001) and in patients with myosteatosis (65.2 ± 19.2 versus 46.7 ± 17.1 μg/dL, P < 0.001) and inversely correlated to both parameters. Survival was significantly lower in malnourished patients compared to patients without myosteatosis or sarcopenia (P < 0.001). Conclusion: Myosteatosis and sarcopenia, probably by reducing the handling of ammonia in the muscle, are independently associated with MHE and the risk of overt HE in patients with cirrhosis; in malnourished patients, the amelioration of nutritional status may be a goal to decrease both the prevalence of MHE and the incidence of overt HE.
引用
- Nardelli S, Lattanzi B, Merli M, et al. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology. 2019. PMID: 31038758. doi:10.1002/hep.30692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。